GLAND PHARMA
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Gland Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.61₹ -30.45
As on Sep 8, 2025, 4:01 PM IST
Gland Pharma Price Performance
Today's LowToday's High
₹1,856.95₹1,907.55
₹1,863.00
52 Weeks' Low52 Weeks' High
₹1,200.00₹2,130.00
₹1,863.00
Open Price
₹1,900.00
Prev. Close
₹1,893.45
Volume
4,529
Over the last 5 years, the share price of Gland Pharma has gained 0.46% CAGR. Over the past year, the corresponding return has been -2.20%.
Gland Pharma’s current P/E of 27.02x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Gland Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gland Pharma | -0.21 | -4.70 | 13.55 | 14.31 | -2.20 | -8.78 | 0.46 |
| Sun Pharmaceutical Industries | -0.78 | -0.78 | -5.85 | -2.01 | -13.26 | 21.24 | 25.25 |
| Divi's Laboratories | -1.44 | -1.69 | -7.95 | 8.31 | 17.31 | 18.93 | 13.53 |
| Cipla | -2.94 | 3.75 | 2.60 | 5.54 | -4.28 | 14.02 | 16.57 |
| Torrent Pharmaceuticals | 1.42 | 2.38 | 14.43 | 18.01 | 5.64 | 33.78 | 21.00 |
| Mankind Pharma | 4.34 | 0.99 | 9.59 | 13.38 | 6.37 | 21.89 | 12.61 |
| Dr. Reddy's Laboratories | -1.00 | 4.45 | -5.31 | 9.80 | -6.27 | 13.84 | 7.17 |
| Zydus Lifesciences | 2.89 | 8.16 | 5.12 | 11.27 | -8.30 | 39.57 | 22.21 |
| Lupin | 2.75 | 5.06 | -2.70 | -3.68 | -13.82 | 43.89 | 16.03 |
| Abbott India | -1.77 | -5.13 | -2.55 | -0.25 | 3.31 | 19.16 | 13.46 |
| Alkem Laboratories | 0.38 | 9.16 | 9.41 | 11.96 | -15.55 | 20.39 | 13.55 |
| Aurobindo Pharma | 1.22 | -3.03 | -10.38 | -6.60 | -32.39 | 24.62 | 5.54 |
| Glenmark Pharmaceuticals | 6.58 | 1.30 | 28.98 | 46.97 | 20.47 | 76.01 | 34.44 |
| Biocon | 4.46 | 0.90 | 10.22 | 9.23 | -2.71 | 7.58 | -2.93 |
| Laurus Labs | 4.62 | 7.23 | 39.59 | 54.47 | 86.10 | 16.91 | 30.13 |
| GlaxoSmithKline Pharmaceuticals | 1.00 | 3.67 | -18.07 | 4.49 | -0.70 | 25.57 | 11.58 |
| Anthem Biosciences | 0.17 | 13.43 | 12.27 | 12.27 | 12.27 | 3.93 | 2.34 |
| Cohance Lifesciences | 14.99 | 8.04 | -4.13 | -12.97 | -15.72 | 27.86 | 24.56 |
| Ipca Laboratories | -4.46 | -4.81 | -3.70 | -3.10 | -7.30 | 14.31 | 5.29 |
| Ajanta Pharma | 4.06 | 1.47 | 0.41 | 0.50 | -23.10 | 24.18 | 20.47 |
Over the last one year, Gland Pharma has declined 2.20% compared to peers like Sun Pharmaceutical Industries (-13.26%), Divi's Laboratories (17.31%), Cipla (-4.28%). From a 5 year perspective, Gland Pharma has underperformed peers relative to Sun Pharmaceutical Industries (25.25%) and Divi's Laboratories (13.53%).
Gland Pharma Financials
Gland Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,873.34 | 1,886.94 |
| 10 | 1,902.55 | 1,897.33 |
| 20 | 1,925.94 | 1,915.8 |
| 50 | 1,931.07 | 1,888.92 |
| 100 | 1,735.47 | 1,809.71 |
| 200 | 1,690.46 | 1,753.33 |
Gland Pharma Share Holding Pattern
In the latest quarter, Gland Pharma remained same as its previous close in promoter holding, while DII stake decreased to 32.86%, FII holding rose to 7.39%, and public shareholding moved down to 7.93% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Gland Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| HDFC Mid-Cap Opportunities Fund - Regular Plan | 56,51,922 | 1.39 | 1,167.01 |
| Mirae Asset Large & Midcap Fund | 29,23,448 | 1.49 | 603.63 |
| SBI Large & Midcap Fund | 29,00,000 | 1.8 | 598.79 |
| Nippon India Growth Fund | 28,00,000 | 1.5 | 578.14 |
| ICICI Prudential India Opportunities Fund | 22,17,343 | 1.54 | 457.84 |
| Mirae Asset Large Cap Fund | 21,45,611 | 1.11 | 443.03 |
| Mirae Asset ELSS Tax Saver Fund | 19,52,663 | 1.55 | 403.19 |
| Nippon India Small Cap Fund | 17,80,371 | 0.56 | 367.61 |
| Nippon India Multi Cap Fund | 14,66,415 | 0.66 | 302.79 |
| HDFC Large and Mid Cap Fund - Regular Plan | 14,00,000 | 1.09 | 289.07 |
Gland Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 29, 2025, 3:47 AM IST | Gland Pharma - Announcement under Regulation 30 (LODR)-Change in Management |
| Aug 29, 2025, 3:38 AM IST | Gland Pharma - Announcement under Regulation 30 (LODR)-Change in Directorate |
| Aug 29, 2025, 3:28 AM IST | Gland Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM |
| Aug 26, 2025, 5:27 PM IST | Gland Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Aug 25, 2025, 8:37 PM IST | Gland Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About Gland Pharma
Gland Pharma Ltd. is a Public Limited Listed company incorporated on 20/03/1978 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1978PLC002276 and registration number is 002276. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 4116.15 Cr. and Equity Capital is Rs. 16.48 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressSy.No. 143-148, 150 & 151, Hyderabad Telangana 500043
- Contact
Management
- Mr. Srinivas SaduExecutive Chairman
- Mr. Wenjie ZhangNon Exe.Non Ind.Director
- Mr. Wei HuangNon Exe.Non Ind.Director
- Dr. Jia Ai (Allen) ZhangNon Exe.Non Ind.Director
- Mr. Essaji Goolam VahanvatiIndependent Director
- Mr. Udo Johannes VetterIndependent Director
- Mr. Satyanarayana Murthy ChavaliIndependent Director
- Ms. Naina Lal KidwaiIndependent Director
FAQs on Gland Pharma Share Price
What is the share price of Gland Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gland Pharma is ₹1,863.00 as on Sep 08, 2025.
What kind of stock is Gland Pharma?
The Gland Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Gland Pharma?
The market cap of Gland Pharma is ₹30,694.12 Cr as on Sep 08, 2025.
What are today's High and Low prices of Gland Pharma?
Today’s highest and lowest price of Gland Pharma are ₹1,907.55 and ₹1,856.95.
What are the 52 Week High and 52 Week Low of Gland Pharma?
The 52-week high/low is the highest and lowest price at which Gland Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Gland Pharma is ₹2,130.00 and 52-week low of Gland Pharma is ₹1,200.00 as on Sep 08, 2025.
How has the Gland Pharma performed historically in terms of returns?
The Gland Pharma has shown returns of -1.61% over the past day, -4.7% for the past month, 13.55% over 3 months, -2.2% over 1 year, -8.78% across 3 years, and 0.46% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Gland Pharma?
P/E ratio of and PB ratio of Gland Pharma are 27.02 and 3.35 on Sep 08, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data